4//SEC Filing
Graham Jonathan P 4
Accession 0001127602-25-013781
CIK 0000318154other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:53 PM ET
Size
7.6 KB
Accession
0001127602-25-013781
Insider Transaction Report
Form 4
AMGEN INCAMGN
Graham Jonathan P
EVP & Gen. Counsel & Secy.
Transactions
- Award
Nqso (Right to Buy)
2025-05-06$270.44/sh+20,554$5,558,624→ 20,554 totalExercise: $270.44From: 2026-05-06Exp: 2035-05-06→ Common Stock (20,554 underlying) - Award
Common Stock
2025-05-06+3,180→ 33,517 total
Footnotes (3)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 352 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F3]These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001365306
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:53 PM ET
- Size
- 7.6 KB